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Abstract
Background: Tumor suppressive let-7 miRNAs are universally down-regulated in human hepatocellular carcinoma
(HCC) versus normal tissues; however, the roles and related molecular mechanisms of let-7 in HCC stem cells are
poorly understood.
Methods: We examined the inhibitory effect of let-7 miRNAs on the proliferation of MHCC97-H and HCCLM3
hepatic cancer cells by using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, which was
further confirmed by apoptosis and cell cycle studies. The sphere-forming assay was used to study the effects of
let-7a on stem like cells. Through western blot, immunofluorescence and the luciferase-reporter assay, we explored
the activity of epithelial-mesenchymal transition (EMT) signaling factors in HCC cells. qRT-PCR was applied to detect
miRNA expression levels in clinical tissues.
Results: Let-7a effectively repressed cell proliferation and viability, and in stem-like cells, also let-7a decreased the
efficiency of sphere formation.in stem-like cells. The suppression of EMT signaling factors in HCC cells contributed
to let-7’s induced tumor viability repression and Wnt activation repression. Besides, Wnt1 is critical and essential for
let-7a functions, and the rescue with recombinant Wnt1 agent abolished the suppressive roles of let-7a on
hepatospheres. In clinical HCC and normal tissues, let-7a expression was inversely correlated with Wnt1 expression.
Conclusions: Let-7 miRNAs, especially let-7a, will be a promising therapeutic strategy in the treatment of HCC through
eliminating HCC stem cells, which could be achieved by their inhibitory effect on the Wnt signaling pathway.
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Background
Hepatocellular carcinoma (HCC) is one of the most
aggressive malignancies worldwide, being recognized as
the third leading cause of cancer-related deaths [1, 2].
HCC is the fifth most common malignancy in men and
the seventh among women [3]. The incidence of HCC
depends on geography, and most of the burden is in
developing countries, occurred with hepatitis. The situ-
ation is more severe in China, with poorer 5-year sur-
vival [4]. The tumorigenesis of HCC is a multistage
process including noncoding and protein-coding genes.
MiRNAs are found to be deregulated in most malignan-
cies, affecting carcinogenesis, progression, metastasis
and tumor recurrence. In HCC, it has been reported
that aberrant expression of let-7 miRNAs contributed
to the development and progression of HCC [5, 6].
Research has indicated that some miRNAs may func-
tion as oncogenes when up-regulated in HCC; to the
contrary, the down-regulated miRNAs suggested them
as tumor suppressors [7, 8]. Functioning as tumor
suppressors, let-7 miRNAs were found to repress Ras,
Bcl-xl, MAPK, c-Myc, cyclin D1 and other oncogenes
in HCC [8, 9]. Wnt1 stimulates the Wnt/β-catenin/TCF
pathway, leading to different cell fates, and then
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regulating the transcription of many downstream genes
which contain the TCF/LEF1 motif, affecting biological
functions and the maintenance of self-renewal of cancer
stem cells (CSCs) [10–12]. However, there is no re-
search focused on the relationship between let-7 and
the Wnt signaling pathway.
Tumors consist of cells with heterogeneity, with differ-
ent characteristics, and the CSCs are demonstrated to be
steady and stable through clinical chemo-radiotherapy,
due to the slow cell cycles and low proliferative ability,
contributing to tumor relapse and occurrence of resist-
ance [8, 13]. Therefore, treatments targeting these silent
CSCs will show great potential in eliminating the tumor
group entirely, helping to overcome resistance to therapy
and recurrence of the tumor. However, the underlying
mechanism by which let-7 works to inhibit CSCs in
HCC remains largely unknown.
Methods
Cell culture, transfection and infection
MHCC97-H and HCCLM3 human HCC cells were pur-
chased from ATCC and maintained at the central
laboratory of the Qilu Hospital of Shandong University.
The cells are cultured in DMEM medium (Invitrogen,
USA), containing 10 % fetal bovine serum (FBS), 1 %
penicillin and 1 % streptomycin (Invitrogen, USA). The
spheres (hepatospheres) were cultured in DMEM/Ham’s
F-12 medium compounded with 10 ng/ml epidermal
growth factor, 10 ng/ml human basic fibroblast growth
factor, 4 μg/ml insulin, 1 % penicillin and 1 % strepto-
mycin (Invitrogen, USA). Oligonucleotides encoding
mature let-7a/b/c/d/e/f/g/i miRNAs and miRNA-LSC1
were synthesized by Invitrogen and cloned into the len-
tiviral vector lentilox3.7 (pLL3.7). SiRNAs targeting
Wnt1were synthesized and purchased from Gene-
Pharma Inc. (Shanghai, China). Transfections were per-
formed using Lipofectamine 2000 (Invitrogen, USA),
and the siRNAs were added the second days after cells
were plated. Transiently transfected HCC cells were
harvested 48 h post-transfection.
Reverse transcription PCR and real-time PCR
Total RNA was isolated from fresh clinical specimen
using TRIzol® Reagent (Invitrogen, USA) following
mechanical tissue homogenization, or from or cultured
cells using Trizol reagent after treatment with 5 μg/ml
puromycin for 48 h. Approximately 1 μg of RNA was
reverse-transcribed to single strand cDNA using Prime-
Script RT Master Mix (Takara Biotechnology, China).
The real-time PCR was conducted in a total volume of
25 μl as previously reported [7, 14]. The cycle threshold
(Ct) was automatically calculated by iQ™-5 Optical
Module software (Bio-rad, USA). The relative expres-
sion of let-7 family members was normalized to U6
expression, and then calculated using the formula 2−ΔΔCt
method, versus the scramble control.
Sphere formation assays
The spheres formation assay is often used to enrich
stem-like cells, being are used to isolate and expand
population enriched in CSCs [15–18]. Cells of different
groups were seeded in ultra-low adherent-conditioned
plates (Corning, USA) to test their ability of forming pri-
mary spheres, in the presence of puromycin. In total,
12,000 cells were seeded per 6 cm plate. On day 9, cell
sphere number of spheres was counted using an inverted
microscope, a sphere was defined as contaning more
than 10 cells. The sphere-forming efficiency was calcu-
lated as the percentage of counted spheres versus seeded
cells [19]. Spheres of different groups were disaggre-
gated, and 12,000 cells were then re-suspended per 6 cm
plate to test their self-renewal ability.
Immunofluorescence and IHC
Cells were seeded on glass chamber slides for 24 h, and
then fixed by 10 % formalin for 15 min. Antigens were
blocked with 2 % normal goat serum (ab7481, Abcam,
USA), cells werethen incubated with the β-catenin anti-
body for 1 h in PBS, and then incubated with Alexa
Fluor® 488 (Life technologies, USA) for 30 min, washed
in PBS, incubated for 10 min with 2 μg/ml of Hoechst
33342 (Life technologies, USA), and washed with PBS
again. For IHC, the paraffin tissues were rehydrated in
an alcohol gradient and then were rinsed in deionized
water. Endogenous peroxidase activity was blocked using
a 0.03 % hydrogen peroxide solution. 1:200 IHC-TekTM
Antibody Diluent (IW-1000, Ellicott City, MD, USA)
was used to reduce background staining. The section
was then incubated with 1 μg/ml ab16051 for 1 h at
room temperature and detected using an HRP, DAB was
used as the chromogen.
Flow cytometry analysis
The propidium iodide (PI) and Annexin V-FITC (Green)
kits were obtained from BD Biosciences (San Jose, CA).
Cells of different groups were collected and trypsinized into
a single cell, and then washed twice with PBS. All cells were
resuspended in 500 μl binding buffer respectively, and 5 μl
of Annexin V-FITC and 10 μl of PI were added. The mix-
ture was gently vortexed and then incubated for 15 min at
room temperature in the dark. The cells were analyzed by
FACSAria cytometry within 1 h of incubation using BD
FACSuite Software. For cell cycle analysis, 5 × 105 cells were
collected and washed twice with PBS. Cells were fixed with
ice-cold 70 % ethanol at 4 °C for 24 h. Before detection, the
fixed cells were stained with PI for 30 min at 37 °C,
followed by FACSAria cytometry. All tests were performed
in triplicate. Cell cycle analysis of DNA content was
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performed using MultiCycle software. Instrument Setup




The TCF/lymphoid enhancer factor luciferase reporter
(TOP) and its negative control (FOP) plasmids were ob-
tained from Upstate Biotechnology (NY, USA). Cells
were plated at 30–40 % confluence in 24-well plates
16 h prior to transfection by using FuGENE 6 (Roche,
USA) [20].
Let-7 and Wnt1 expression in clinical tissues
To explore the role of let-7a in HCC, we first collected
specimens from 58 patients, who underwent surgery at
the Department of General Surgery, the Second Hospital
of Jilin University from June 2008 to November 2013. Of
the samples collected, 20 slides were prepared for IHC
using a Wnt 1 (1:200; sc-6280, Santa Cruz, USA). All of
the patients were diagnosed and confirmed by patho-
logical examination. No preoperative chemotherapy or
radiotherapy was performed in any of these patients.
Specimens were stored in liquid nitrogen. This study
was conducted under the supervision of the Ethical
Board of Jilin University.
Statistical analysis
All data were obtained from at least three independent
experiments, are expressed as mean ± SD and were ana-
lyzed by Student’s T-test and χ2 test using SPSS for
Windows version 16.0 (IBM, USA) and Excel 2010
(Microsoft, USA).
Results
The function of let-7 miRNAs in HCC cells
RFP based let-7a/b/c/d/e/f/g/i lentiviral vectors were
successfully infected into HCC cells, asshown in Fig. 1.
Inhibition of cell proliferation was detected using MTT
assay at 48 h. The proliferation of let-7a-overexpressing
HCC cells was suppressed most effectively compared to
scramble and empty vector groups, as determined by the
Student’s T-test (p < 0.01) and ANOVA (p < 0.01) analysis
with Bonferroni correction (Fig. 2a).
Overexpressing let-7a induced apoptosis and cell cycle
arrest of HCC cells
To examine whether the enforced let-7a could induce
cell apoptosis and cell cycle arrest, both MHCC97-H
and HCCLM3 cell lines were subjected to Flow cytome-
try analysis. We found that both of these HCC cell lines
exhibited higher apoptosis ratios (T-test, p < 0.01, Fig. 2b).
Let-7a also induced cell cycles arrest at G1 (T-test, p < 0.01,
Fig. 1 The construction of let-7 miRNAs overexpressing HCC cells. a. The expression levels of let-7 miRNAs in HCC cells were detected after
lentivirals infection, and results showed that we successfully constructed let-7 overexpressing HCC cells. The lentivirals vectors infected cells
were red when observed under Inversed Fluorescent Microscope
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Fig. 2c). Representative images of apoptosis and cell cycle
are shown in Fig. 2d-e.
Let-7a suppressed the sphere formation efficiency of
HCC cells
Sphere formation efficiency of MHCC97-H-let-7a and
HCCLM3-let-7a cells was significantly lower than that
of Scramble groups (T-test, p < 0.01, Fig. 3a). Disaggrega-
tion of primary hepatospheres and secondary plating of
suspending cells led to the formation of hepatospheres
again, and the sphere forming efficiency of MHCC97-H-
let-7a and HCCLM3-let-7a secondary spheres was lower
than that of Scramble groups (T-test, p < 0.01,Fig. 3b), as
were shown in Fig. 3c. To further confirm the effects of
let-7a1 on HCC stem cells, continuous sphere culture
assay was applied, and up to six generations were cul-
tured and detected. Let-7a1 showed significant impacts
on HCC stem cells, and the inhibitive influence could be
accumulated (Fig. 3d).
Overexpressing let-7a suppressed the EMT factors of HCC
cells and Wnt signaling pathway of HCC stem-like cells
We first detected markers related to apoptosis and cell
cycle (Fig. 4a). To explore the possible mechanisms by
which let-7a represses sphere number, we hypothesized
that increased let-7a in HCC cells and HCC stem cells
Fig. 2 The inhibitory effects let-7 on HCC cells. a. After let-7 miRNAs were successfully overexpressing in HCC cells, the effects of let-7 on cell
proliferation were detected by MTT assay. Let-7a was demonstrated to exert the strongest repression on cell proliferation, defined by student
t test and Two-way ANOVA, * p < 0.01. Let-7a induced more cell apoptosis in MHCC97-H and HCCLM3 cells (b); let-7a also increased the portion of
cells staying in G0-G1 stage and decreased the cells in S phase (c), compared to Scramble group. * p < 0.01. The representative images of the FACS
derived apoptosis ratios (d) and FACS derived cell cycle analysis (e)
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inhibited malignant cellular behaviors through down-
regulating N-cadherin and Snail, that has been typical
pathological markers for epithelial trait was up-
regulated; meanwhile, was involved in the process of
epithelial-mesenchymal transition (EMT) (Fig. 4b,
Left). In HCC stem-like cells, key molecules of the
Wnt signaling pathway universally decreased due to
overexpressing let-7a, indicating that let-7a inhibited
the Wnt1/Frizzled/β-catenin pathway in a population
enriched with HCC stem cells (Fig. 4b, right). Further,
using the luc-reporter assay and immunofluorescence
staining, we found that let-7a inhibited Wnt signaling,
which was achieved by decreasing TCF-4 promoter ac-
tivity (T-test, p < 0.01, Fig. 4c) and β-catenin expres-
sion (Fig. 4d).
Decreased Wnt1 is required for let-7a-induced renewal
inhibition of hepatospheres
We used the RNA interference assay to suppress Wnt1
activity in HCC cells by three independent siRNA. As
with let-7a1 overexpression, knockdown of Wnt1 signifi-
cantly inhibited the self-renewal ability of stem-like cells,
and inhibited Wnt signaling pathway factors (Fig. 5a). In
the presence of Wnt1 siRNA, let-7a1 did not show sig-
nificant inhibition on sphere formation ability in con-
tinuous stem cell culture compared to the scramble
control (Fig. 5b). The knockdown of Wnt1 decreased
TCF-4 activity significantly, abolishing let-7a functions
(Fig. 5c). To identify whether Wnt1 is critical for let-
7a-repressed self-renewal ability of HCC stem cells,
MHCC97-H and HCCLM3 cells were cultured in
Fig. 3 Let-7a1 inhibits the capacity of self-renewal of HCC stem cells. The HCC cells were seeded in ultra-low attachment plates to form the 1st
generation of spheres. Then the cell form spheres were reseeded to acquire the 2nd generation of spheres. The sphere forming efficiency of the
first generation (a) and the second generation (b) of HCC stem-like cells infected with let-7a1 and Scramble vector, * p < 0.01, with representative
images shown in (c). d Let-7a1 inhibits the self-renewal of HCC stem cells group in continuously cultured spheres, showing much stronger inhibition
than that of control group in total six generations
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ultralow attachment plates with recombinant Wnt1
protein (50 ng/ml) for 8 days. The addition of recom-
binant Wnt1 protein increased the sphere formation
efficiency of both let-7a1 and scramble controls, re-
versing the suppressive roles of let-7a (Fig. 5d), and
also increased TCF-4 activity (Fig. 5c).
Let-7a sensitized HCC stem-like cells to cis-platinum-
induced self-renewal inhibition
Cis-platinum is one of the most commonly used anti-
cancer drugs in clinical treatment; however its role in
the regulation of CSCs is not well understood. We found
that cis-platinum reduced spheres number (Fig. 6a-b)
Fig. 4 The suppressions of EMT factors of HCC cells and Wnt activation of HCC stem cells were related to let-7a functions. a. Gene expression
levels of let-7 targeted genes, which were implicated in cell apoptosis and cell cycle regulations. Let-7a decreased HMGA2, Bcl-xl, MAPK, cyclin d1,
and increased Bcl-2 in both cell lines. b. Genes related to EMT were detected, and results showed that let-7 inhibited the EMT of HCC cells
through regulating E-cadherin, N-cadherin and Snail, of which, E-cadherin was up-regulated, whereas, the mesenchymal biomarker N-cadherin
and Snail were decreased. c. Let-7a1 inhibited the TCF-4 promoter activity of HCC cells, and inhibited Wnt1/Frizzled/β-catenin signaling of
HCC stem cells, which was demonstrated to promote the self-renewal ability of cancer stem cells. d. The results of immunofluorescence showed that
β-catenin was decreased due to let-7 overexpression in HCC stem cells
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through the inhibition of Wnt1 expression (Fig. 6c); the
effects were reversed by recombinant Wnt1 protein
(Fig. 6a). The combined use of cis-platinum and let-7a
significantly decreased the sphere number, inhibiting the
self-renewal ability of HCC stem-like cells through con-
current effects on Wnt signaling.
The loss of let-7a was related to the occurrence and
progress of HCC
IHC studies show that the level of β-catenin was much
higher in tumors with later clinical stages (Fig. 7a-b). In
clinical HCC samples, let-7a expression was much lower
in tumor tissues than adjacent normal tissue (Fig. 7c),
indicating an inverse relationship between let-7a expres-
sion and HCC occurrence. Likewise, let-7a expression
level was inversely correlated with Wnt1 mRNA in HCC
tissues (Fig. 7d).
Discussion
Let-7 is a family consisting of 13 members located on
nine different chromosomes whose expression is usually
lost, reduced, or deregulated in most human malignan-
cies [21]. Growing evidence suggests that the restoration
of let-7 expression effectively repressed cell proliferation,
invasion, metastasis, and resistance to therapy. The find-
ings of let-7 repression on CSC self-renewal indicated
Fig. 5 Let-7a inhibits the HCC spheres through Wnt1. a. The knockdown of Wnt1 (left) decreased the sphere forming efficiency of HCC stem cells,
and abolished the functions of let-7a on self-renewal ability (right), which functioned through regulations of Wnt1/Frizzled/β-catenin pathway
(left). b. In continuous culture of HCC spheres, the Wnt1 siRNA didn’t affect the self-renewal ability of let-7a1 overexpressing HCC stem-like cells,
compared to Control group (VEH). c. The knockdown of Wnt1 decreased TCF-4 activity, abolished let-7a effects; similarly, the addition of Wnt1
reversed let-7a effects, increasing TCF-4 activity, and no significant differences between let-7a and Scramble group were detected. d. The addition
of Wnt1 reversed the suppressive effects of let-7a on MFE
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that let-7 restoration may be a useful therapeutic option
in HCC and stem-like cells, which was more crucial for
curing the cancer [8, 22–24]. Recent studies found that
cholesterol-conjugated let-7a inhibited cell proliferation,
growth, and metastasis, and mainly functioned in the
cytoplasm through directly reaching HCC orthotropic
tumors [25]. What’s more, the therapeutic trial of let-7
mimics showed suppressed effects on tumor growth in
pre-clinical studies [4]. Especially, nanoparticle-based
let-7 replacement therapy had been successfully applied
in vivo, together with other delivery methods, including
lentivirus-mediated pre–let-7 s, adenovirus-mediated
hairpin sequences of mature let-7, cationic liposome–
mediated pre–let-7, and electroporation of synthetic
let-7 [8, 26].
In this study, we show that overexpressing let-7a
exerted inhibitory effects on HCC, consistent with previ-
ously published results for other malignancies [27, 28].
EMT inducers, including Snail, Slug, Twist1, ZEB1 and
ZEB2, suppress the expression of adherence proteins to
induce cellular malignancies. EMT is a major mechan-
ism for cancer generation, metastasis and progression
[8], which ultimately promote the growth of tumor bulk
and cell proliferation, and during the EMT process,
CSCs are generated [29]. We found that increased let-7a
could inhibit sphere formation efficiency through allevi-
ating EMT via down-regulating N-cadherin and Snail in
HCC cells. In HCC stem-like cells, overexpressing let-7a
inhibited the Wnt1/Frizzled/β-catenin signaling pathway,
which was involved in maintaining the self-renewal abil-
ity of stem cells. We further identified that repressed
Wnt1/Frizzled/β-catenin signaling in a CSC-enriched
population was attributed to enforced let-7 and let-7 en-
hanced cis-platinum functions, helping to inhibit the
self-renewal of stem-like cells. Our results suggest that
overexpression of let-7a could be used as a therapeutic
agent and prognostic indicator in the management of
HCC against Wnt activation, and help to understand the
mechanisms through which let-7 regulated HCC stem
cells.
Let-7 functions are detailed explored in many kinds of
tumors, and let-7 acted through post-transcriptional reg-
ulations of the targeted genes [30]. However, the roles of
let-7 in HCC stem-like cells are less involved. For the
first time, we identified the let-7 controlled Wnt signal-
ing activity, which was accused for maintaining of cell
pluripotency. Wnt/β-catenin transactivation of let-7 in
breast cancer further suggested the regulatory roles of
let-7 in stem cells’ regulations [31]. Overall, our results
suggest that overexpression of let-7a could be used as a
Fig. 6 Let-7a sensitized HCC stem-like cells to cis-platinum induced self-renewal inhibition. a. Cis-platinum reduced sphere number through
inhibition of Wnt1 expression. b. The combined use of cis-platinum and let-7a significantly decreased the sphere number, inhibiting the
self-renewal ability of HCC stem-like cells through concurrent effects on Wnt signaling. c. Both let-7a and cis-platinum inhibited Wnt1 explression level,
and exerted sygnergic inhibition on Wnt1 activity
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therapeutic agent and prognostic indicator in the manage-
ment of HCC via repression of Wnt signaling activation in
stem cells, and to help understand the mechanisms
through which let-7 regulates HCC stem cells.
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